Reporting Owner Activity for James W. Mccollum

Location

Del Mar, CA

Ownership summary

The estimated value of James W. Mccollum's disclosed insider holdings is at least $29,146,779 as of 10 Nov 2025.

Director: LENZ Therapeutics, Inc. (LENZ) reported at about $29.15M

Values are based on parsed SEC Forms 3/4/5 and should be verified against the source filing.

Signature

/s/ Daniel R. Chevallard, as Attorney-in-Fact

Source filings

Open source filing history

Follow Filing Activity

Follow James W. Mccollum and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

James W. Mccollum has 1 issuer position tracked on this page.
Estimated disclosed ownership value: $29,146,779.
Recent insider filing activity is available below.

Change

Largest disclosed position: LENZ Therapeutics, Inc. ($29,146,779).
Past-year value change for that position: +$239,278.

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Reported issuer positions for James W. Mccollum

LENZ Forms 3/4/5

LENZ Therapeutics, Inc.

Relationship: Director
Holdings value: $29,146,779
Past year net change: +$239,278
Change %: +0.83%
Report period: 07 Nov 2025

Insider Transactions Reported by James W. Mccollum:

Sym	Company	Class	Transaction	%	Reported value	Reported price	Shares	Shares after	Date	Ownership

An asterisk next to the price means the reported price is likely invalid.